AEGiS-SC: Sharing A Needle Risks More Than AIDS/Hepatitis also spreads among drug addicts San Francisco ChronicleImportant note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Click here to return to San Francisco Chronicle main menu
DonateNow


Sharing A Needle Risks More Than AIDS/Hepatitis also spreads among drug addicts

The San Francisco Chronicle - Monday, September 27, 1999
David Perlman, Chronicle Science Editor


Despite the success of needle exchange programs in preventing the spread of AIDS among injection- drug users, a new epidemic is emerging to threaten addicts with still another deadly disease.

Researchers call the problem "co- infection," but to addicts on the streets and in the hidden alleys of major cities, it means that when they share needles they risk not only AIDS but also infection with the hepatitis C virus that causes chronic liver disease and fatal liver cancer.

One of the earliest volunteer needle exchange efforts took place in Vancouver, British Columbia, with vans roving inner-city streets each night to bring clean needles and disinfectant to addicts wherever they gathered.

When some of the addicts who declined the free needles developed AIDS and sought treatment at the city's clinics, doctors who examined them began observing an increase in positive blood tests for the hepatitis C virus.

INJECTION USERS' HIGH RISK

In February, a team at St. Paul's Hospital in Vancouver opened a new AIDS clinic specifically aimed at testing and treating patients who are co-infected with HIV, the AIDS virus, and the hepatitis C virus.

The clinic is keeping long-term records of its patients, and some of its latest findings were reported in San Francisco yesterday by Dr. Dwight Ferris of Vancouver at the opening of a meeting in Moscone Center called the Interscience Conference on Antimicrobial Agents and Chemotherapy -- known to researchers as ICAAC.

In a study comparing drug users who came to the clinic and patients who did not inject drugs -- all of whom were infected by the AIDS virus -- clinic doctors found that 100 percent of the injection drug users were also infected with the hepatitis C virus, while the virus showed up in only 25 percent of those who did not inject drugs.

The injection drug users were also much less likely than the nonusers to be taking new and powerful combinations of anti-AIDS medicines known as highly active anti-retroviral therapy, Ferris reported.

THE ALCOHOL FACTOR

Heavy alcohol drinking was also a distinctive characteristic of the injection drug users who were co-infected with hepatitis C.

The urgent need now, Ferris said, is to develop "a new standard of care for HIV-infected individuals with hepatitis," as well as more effective strategies for treating the alcohol abusers among them whose combination of afflictions poses a formidable challenge for all AIDS caregivers.

The huge ICAAC meeting, attended by more than 16,000 medical researchers, drug company representatives and health care workers, is expected to fill Moscone Center's immense exhibit halls and conference rooms through Wednesday.
990927
SC990903


Copyright © 1999 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com.   http://www.sfgate.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .